𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P1068 EFFICACY OF PROLONGED TENOFOVIR THERAPY ON HEPATITIS DELTA IN HIV-INFECTED PATIENTS

✍ Scribed by Sierra-Enguita, R.; Vispo, E.; Barreiro, P.; de Mendoza, C.; Fernandez-Montero, J.V.; Labarga, P.; Soriano, V.

Book ID
122127498
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
59 KB
Volume
60
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-hepatitis B virus efficacy of tenof
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients
✍ Yves Benhamou; Herve Fleury; Pascale Trimoulet; Isabelle Pellegrin; Renaud Urbin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

for the TECOVIR Study Group Tenofovir disoproxil fumarate (TDF) has shown in vitro activity against both HIV and hepatitis B virus (HBV). We retrospectively evaluated the efficacy of TDF (300 mg/d), administered as a part of anti-retroviral therapy, in a large cohort of HIV/HBV-coinfected patients.

Efficacy and safety of tenofovir double-
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: The tenoplus study
✍ Stephanie Dominguez; Jade Ghosn; Gilles Peytavin; Hassan Izzedine; Marc Wirden; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract Drug resistance is an increasing problem in the treatment of HIV infection. Tenofovir has been shown to inhibit HIV replication even with thymidine‐associated resistance mutations (TAMs) if they are limited to two or less. Double‐dose of tenofovir disoproxil fumarate (TDF) (600 mg QD) w